Worldwide, there are 1.3 billion presbyopes and more than 14 million cataract procedures performed annually.
Visiogen is dedicated to bringing a new world of vision to patients experiencing these two common ophthalmic
conditions. The company plans to revolutionize the field of cataract surgery by offering the Synchrony® dual optic
accommodating IOL. This long-awaited, 3-dimensional device represents a major breakthrough in ophthalmic technology—an IOL that is designed to allow patients to have a continuous range of focus without the use of
spectacles or the optical disadvantages of monovision or multifocal implants. Founded in 2001, Visiogen is a
privately held company located in Irvine, California.
Bringing a New World of Vision to Life
Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision
alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created
the Synchrony dual optic accommodating intraocular lens (IOL) for use in the surgical treatment of these
conditions. The device is designed to provide patients with near, intermediate and distance vision in a
seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery,
the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved
in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States. The
Synchrony system reflects the Visiogen team’s notable scientific expertise and experience in the field of
ophthalmic medical devices. This knowledge is combined with a high level of business acumen to optimize the
company’s potential for success.
Our Management Team
It takes a dedicated group of experts to develop an innovative ophthalmic device such as
the Synchrony dual optic accommodating intraocular lens with pre-loaded injector. The management team at Visiogen is made up of scientists, engineers, clinicians, and industry leaders with extensive experience in developing and commercializing ophthalmic products. Together with a panel of highly-renowned surgeons, this team was the first in the world to successfully implant dual optic lenses in cataract patients during an investigational trial.
This is all supported by Visiogen’s investors and board members, who offer a wealth of knowledge related to growing successful ophthalmic companies.
Technological Standards
The Visiogen team recognizes that its work may have a significant impact on the quality of life for millions of people.
The company has developed an in-house research, development, and manufacturing structure that is fully
compliant with the highest standards set forth for the production of ophthalmic devices in the United States and
Europe. This includes maintaining a state-of-the-art clean room that is equipped to meet the most exacting
requirements of the industry.
